The question of whether both insulin use and advanced CKD are independently associated with increased risk of hypoglycemia may have therapeutic implications for glycemic control in persons with T2D and CKD as hypoglycemic episodes are associated with increased risk of CKD progression [10], stroke [11] and mortality [12, 13]. This evidence concerns the gene INS and Hypoglycemia.